Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Use of Bayesian networks to dissect the complexity of genetic disease: application to the Genetic Analysis Workshop 17 simulated data

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

From Genome-Scale Data to Models of Infectious Disease: A Bayesian Network-Based Strategy to Drive Model Development

Bayesian Neural Networks for Genetic Association Studies of Complex Disease

Gene-gene interaction analysis incorporating network information via a structured Bayesian approach

Block-based Bayesian epistasis association mapping with application to WTCCC type 1 diabetes data

Estimation of causal effects of genes on complex traits using a Bayesian-network-based framework applied to GWAS data

Disease Gene Explorer: Display Disease Gene Dependency by Combining Bayesian Networks with Clustering

Network-based Analysis of Complex Diseases.

Joint network and node selection for pathway-based genomic data analysis.

Bayesian network analysis incorporating genetic anchors complements conventional Mendelian randomization approaches for exploratory analysis of causal relationships in complex data

Application of Bayesian Networks on Large-Scale Biological Data

Bayesian optimization algorithm-based methods searching for risk/protective factors

NSPA: characterizing the disease association of multiple genetic interactions at single-subject resolution

Integrating Embeddings of Multiple Gene Networks to Prioritize Complex Disease-Associated Genes

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

Evaluation of Bayesian Linear Regression Models for Gene Set Prioritization in Complex Diseases

Bayesian Mendelian Randomization Analysis for Latent Exposures Leveraging GWAS Summary Statistics for Traits Co-Regulated by the Exposures

Integrating Multiple Protein-Protein Interaction Networks to Prioritize Disease Genes: a Bayesian Regression Approach

High-Dimensional Bayesian Network Inference From Systems Genetics Data Using Genetic Node Ordering

Advances to Bayesian network inference for generating causal networks from observational biological data